This Government Contract opportunity from Department Of Health And Human Services was posted on May 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Enzyme-Based and Biochemical Assay Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the development and execution of enzyme inhibition or activation assays aimed at understanding the mechanism of action of small-molecule candidates that target cancer-related pathways. This work is focused on enzyme-based and biochemical assay development to support cancer research and drug discovery efforts. The contract is a subcontract opportunity issued by the National Institutes of Health under the Department of Health and Human Services, with the place of performance located in Bethesda, Maryland. The solicitation was posted on May 29, 2026, with a response deadline of June 8, 2026. The contract falls under the NAICS code 541380, which pertains to testing laboratories, and is classified as a subcontract without any specified set-aside provisions. The primary objective is to support the assessment of novel molecules for their enzymatic activity modulation, ultimately contributing to the identification and validation of therapeutic candidates against cancer.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
